Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1949 2
1950 2
1951 3
1952 1
1955 3
1956 5
1957 2
1958 5
1959 1
1960 4
1961 3
1962 1
1965 2
1966 2
1968 2
1969 2
1970 1
1975 4
1976 2
1977 2
1978 1
1979 5
1980 2
1982 1
1983 1
1984 1
1985 1
1986 3
1987 2
1988 1
1989 2
1990 1
1991 6
1992 5
1993 4
1994 1
1995 2
1996 1
1997 1
1999 1
2000 3
2001 16
2002 5
2003 7
2004 11
2005 12
2006 15
2007 5
2008 16
2009 16
2010 11
2011 18
2012 10
2013 11
2014 17
2015 11
2016 15
2017 11
2018 18
2019 11
2020 9
2021 9
2022 9
2023 10
2024 9
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

369 results

Results by year

Filters applied: . Clear all
Page 1
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer.
Zhou Y, Börcsök J, Adib E, Kamran SC, Neil AJ, Stawiski K, Freeman D, Stormoen DR, Sztupinszki Z, Samant A, Nassar A, Bekele RT, Hanlon T, Valentine H, Epstein I, Sharma B, Felt K, Abbosh P, Wu CL, Efstathiou JA, Miyamoto DT, Anderson W, Szallasi Z, Mouw KW. Zhou Y, et al. Among authors: epstein i. Sci Adv. 2023 Nov 24;9(47):eadg2263. doi: 10.1126/sciadv.adg2263. Epub 2023 Nov 22. Sci Adv. 2023. PMID: 37992168 Free PMC article.
Peptide-Modulated pH Rhythms.
Liu M, Yuan L, Zhu C, Pan C, Gao Q, Wang H, Cheng Z, Epstein IR. Liu M, et al. Among authors: epstein ir. Chemphyschem. 2022 Aug 17;23(16):e202200103. doi: 10.1002/cphc.202200103. Epub 2022 Jun 21. Chemphyschem. 2022. PMID: 35648769
Editorial: Advances in Oscillating Reactions.
Cupić ŽD, Taylor AF, Horváth D, Orlik M, Epstein IR. Cupić ŽD, et al. Among authors: epstein ir. Front Chem. 2021 Apr 28;9:690699. doi: 10.3389/fchem.2021.690699. eCollection 2021. Front Chem. 2021. PMID: 33996772 Free PMC article. No abstract available.
Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study.
Fiala O, Massari F, Basso U, Giannatempo P, Grande E, Buti S, Myint ZW, De Giorgi U, Pichler R, Grillone F, Ürün Y, Calabrò F, Bourlon MT, Galli L, Kanesvaran R, Roviello G, Kucharz J, Rizzo M, Park SH, Cerbone L, Seront E, Messina C, Molina-Cerrillo J, Santini D, Yano A, Incorvaia L, Catalano M, Pinto A, Formisano L, Soares A, Facchini G, Fornarini G, Poprach A, Rebuzzi SE, Nasso C, Spinelli GP, Angel M, Stellato M, Tural D, Aurilio G, Epstein I, Carrozza F, Monteiro FSM, Benedetti G, Büchler T, Ortega C, Zakopoulou R, Battelli N, Porta C, Bellmunt J, Gupta S, Santoni M. Fiala O, et al. Among authors: epstein i. Target Oncol. 2024 Nov;19(6):905-915. doi: 10.1007/s11523-024-01099-0. Epub 2024 Oct 1. Target Oncol. 2024. PMID: 39354179 Free PMC article.
Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer.
Ravi P, Freeman D, Thomas J, Ravi A, Mantia C, McGregor BA, Berchuck JE, Epstein I, Budde P, Ahangarian Abhari B, Rupieper E, Gajewski J, Schubert AS, Kilian AL, Bräutigam M, Zucht HD, Sonpavde G. Ravi P, et al. Among authors: epstein i. J Immunother Cancer. 2024 Feb 2;12(2):e008215. doi: 10.1136/jitc-2023-008215. J Immunother Cancer. 2024. PMID: 38309723 Free PMC article.
Insights from chemical systems into Turing-type morphogenesis.
Konow C, Dolnik M, Epstein IR. Konow C, et al. Among authors: epstein ir. Philos Trans A Math Phys Eng Sci. 2021 Dec 27;379(2213):20200269. doi: 10.1098/rsta.2020.0269. Epub 2021 Nov 8. Philos Trans A Math Phys Eng Sci. 2021. PMID: 34743602 Review.
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes.
Bakaloudi DR, Talukder R, Enright T, Leary JB, Makrakis D, Diamantopoulos LN, Hobeika C, Thomas VM, Swami U, Zakopoulou R, Bamias A, Brown JR, Pinato DJ, Latchford C, Jindal T, Koshkin VS, Murgić J, Miletić M, Frobe A, Johnson J, Zakharia Y, Alva A, Nguyen CB, Hui G, Drakaki A, Rodriguez-Vida A, Rey-Cárdenas M, Castellano D, Buznego LA, Duran I, Barrera RM, Marmolejo D, McKay RR, Stewart TF, Barata P, Epstein IB, Bellmunt J, Yu EY, Raychaudhuri R, Nadal R, Vakar-Lopez F, Gupta S, Wright JL, Khaki AR, Grivas P. Bakaloudi DR, et al. Among authors: epstein ib. Clin Genitourin Cancer. 2025 Aug;23(4):102356. doi: 10.1016/j.clgc.2025.102356. Epub 2025 Apr 14. Clin Genitourin Cancer. 2025. PMID: 40378559
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study.
Jindal T, Jiang CY, Alhalabi O, Nguyen CB, Oh E, Tsung I, Bakaloudi DR, Talukder R, Davidsohn M, Freeman D, Epstein IY, Ding CC, Nizam A, Glover MJ, Khaki AR, Taylor AK, Lemke E, Jang A, Evans ST, Shin D, Pywell C, Basu A, Bilen MA, Zakharia Y, Barata P, Milowsky MI, Brown J, Kilari D, Emamekhoo H, Hoimes CJ, Shah S, Davis NB, Gupta S, Grivas P, Bellmunt J, Alva A, Campbell MT, Koshkin VS. Jindal T, et al. Among authors: epstein iy. Eur Urol. 2025 Sep 14:S0302-2838(25)00490-7. doi: 10.1016/j.eururo.2025.09.003. Online ahead of print. Eur Urol. 2025. PMID: 40954009 No abstract available.
369 results